Tower Research Capital LLC (Trc) Immunome Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Immunome Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,136 shares of IMNM stock, worth $26,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,136
Previous 8,608
63.57%
Holding current value
$26,624
Previous $88,000
76.14%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IMNM
# of Institutions
149Shares Held
66.4MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$64.1 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$45.5 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$37 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$36.6 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$34.6 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $103M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...